Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP4 | P12644 | 5/20 | 0.84 |
| ▸ | ACVR1 | Q04771 | 16/20 | 0.57 |
| ▸ | ACVRL1 | P37023 | 15/20 | 0.57 |
| ▸ | BMPR1B | O00238 | 14/20 | 0.57 |
| ▸ | BMPR1A | P36894 | 13/20 | 0.57 |
| ▸ | KDR | P35968 | 3/20 | 0.57 |
| ▸ | ACVR1B | P36896 | 9/20 | 0.52 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.52 |
| ▸ | TGFBR2 | P37173 | 2/20 | 0.52 |
| ▸ | PRKAB1 | Q9Y478 | 2/20 | 0.52 |
| ▸ | BMPR2 | Q13873 | 1/20 | 0.52 |
| ▸ | JAK1 | P23458 | 1/20 | 0.51 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30665011 | 0.91 | BMP4 (1.00) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| SCHEMBL11953871 | 0.91 | BMP4 (1.00) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| SCHEMBL198641 | 0.77 | MAPT (0.64) | BMP4ACVR1 | |
| SCHEMBL16111462 | 0.76 | BMP4 (0.85) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| SCHEMBL12779951 | 0.76 | ACVRL1 (0.78) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| SCHEMBL30074632 | 0.75 | BMP4 (0.57) | BMP4TGFBR1JAK1PIK3C3 | |
| SCHEMBL16111478 | 0.75 | ACVRL1 (0.70) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| SCHEMBL24181952 | 0.73 | BMP4 (0.51) | BMP4JAK1PIK3C3 | |
| SCHEMBL11953869 | 0.73 | ACVR1 (1.00) | BMP4ACVR1ACVRL1BMPR1BBMPR1A | |
| Hydrochloric Acid SCHEMBL30172429 | 0.72 | BMP4 (0.50) | BMP4ACVR1ACVRL1BMPR1BBMPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383624-B2 | Cargo delivery system and composition comprising the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-12 | — | — | US | claimed |
| US-12383624-B2 | Cargo delivery system and composition comprising the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-12 | — | — | US | disclosed |
| US-20230190938-A1 | NOVEL CARGO DELIVERY SYSTEM AND COMPOSITION COMPRISING THE SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190938-A1 | NOVEL CARGO DELIVERY SYSTEM AND COMPOSITION COMPRISING THE SAME | ATG7, SQSTM1, BECN1 | BMP4 3238/4885ACVR1 3474/4885ACVRL1 3047/4885 |
| US-12383624-B2 | Cargo delivery system and composition comprising the same | ATG7, SQSTM1, BECN1 | BMP4 3572/4885ACVR1 3717/4885ACVRL1 3409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.